AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
FREQUENCY OF GERMLINE AND SOMATIC BRCA1 MUTATIONS IN OVARIAN-CANCER
Authors: BERCHUCK A HERON KA CARNEY ME LANCASTER JM FRASER EG VINSON VL DEFFENBAUGH AM MIRON A MARKS JR FUTREAL PA FRANK TS
Citation: A. Berchuck et al., FREQUENCY OF GERMLINE AND SOMATIC BRCA1 MUTATIONS IN OVARIAN-CANCER, Clinical cancer research, 4(10), 1998, pp. 2433-2437
COMPLEX RESPONSE OF BREAST EPITHELIAL-CELL LINES TO TOPOISOMERASE INHIBITORS
Authors: DAVIS PL SHAIU WL SCOTT GL IGLEHART JD HSIEH TS MARKS JR
Citation: Pl. Davis et al., COMPLEX RESPONSE OF BREAST EPITHELIAL-CELL LINES TO TOPOISOMERASE INHIBITORS, Anticancer research, 18(4C), 1998, pp. 2919-2932
PREDICTING RESPONSE TO ADJUVANT AND RADIATION-THERAPY IN PATIENTS WITH EARLY-STAGE BREAST-CARCINOMA
Authors: BURKE HB HOANG A IGLEHART JD MARKS JR
Citation: Hb. Burke et al., PREDICTING RESPONSE TO ADJUVANT AND RADIATION-THERAPY IN PATIENTS WITH EARLY-STAGE BREAST-CARCINOMA, Cancer, 82(5), 1998, pp. 874-877
BRCA1 EXPRESSION IS NOT DIRECTLY RESPONSIVE TO ESTROGEN
Authors: MARKS JR HUPER G VAUGHN JP DAVIS PL NORRIS J MCDONNELL DP WISEMAN RW FUTREAL PA IGLEHART JD
Citation: Jr. Marks et al., BRCA1 EXPRESSION IS NOT DIRECTLY RESPONSIVE TO ESTROGEN, Oncogene, 14(1), 1997, pp. 115-121
ARTIFICIAL NEURAL NETWORKS IMPROVE THE ACCURACY OF CANCER SURVIVAL PREDICTION
Authors: BURKE HB GOODMAN PH ROSEN DB HENSON DE WEINSTEIN JN HARRELL FE MARKS JR WINCHESTER DP BOSTWICK DG
Citation: Hb. Burke et al., ARTIFICIAL NEURAL NETWORKS IMPROVE THE ACCURACY OF CANCER SURVIVAL PREDICTION, Cancer, 79(4), 1997, pp. 857-862
RELATIONSHIP BETWEEN P21 EXPRESSION AND MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IN NORMAL AND MALIGNANT OVARIAN EPITHELIAL-CELLS
Authors: ELBENDARY AA CIRISANO FD EVANS AC DAVIS PL IGLEHART JD MARKS JR BERCHUCK A
Citation: Aa. Elbendary et al., RELATIONSHIP BETWEEN P21 EXPRESSION AND MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IN NORMAL AND MALIGNANT OVARIAN EPITHELIAL-CELLS, Clinical cancer research, 2(9), 1996, pp. 1571-1575
BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS
Authors: LANCASTER JM WOOSTER R MANGION J PHELAN CM COCHRAN C GUMBS C SEAL S BARFOOT R COLLINS N BIGNELL G PATEL S HAMOUDI R LARSSON C WISEMAN RW BERCHUCK A IGLEHART JD MARKS JR ASHWORTH A STRATTON MR FUTREAL PA
Citation: Jm. Lancaster et al., BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS, Nature genetics, 13(2), 1996, pp. 238-240
BRCA1 EXPRESSION IS INDUCED BEFORE DNA-SYNTHESIS IN BOTH NORMAL AND TUMOR-DERIVED BREAST CELLS
Authors: VAUGHN JP DAVIS PL JARBOE MD HUPER G EVANS AC WISEMAN RW BERCHUCK A IGLEHART JD FUTREAL PA MARKS JR
Citation: Jp. Vaughn et al., BRCA1 EXPRESSION IS INDUCED BEFORE DNA-SYNTHESIS IN BOTH NORMAL AND TUMOR-DERIVED BREAST CELLS, Cell growth & differentiation, 7(6), 1996, pp. 711-715
M6P IGF2 RECEPTOR - A CANDIDATE BREAST-TUMOR SUPPRESSOR GENE/
Authors: HANKINS GR DESOUZA AT BENTLEY RC PATEL MR MARKS JR IGLEHART JD JIRTLE RL
Citation: Gr. Hankins et al., M6P IGF2 RECEPTOR - A CANDIDATE BREAST-TUMOR SUPPRESSOR GENE/, Oncogene, 12(9), 1996, pp. 2003-2009
MICROSOMAL EPOXIDE HYDROLASE POLYMORPHISM AS A RISK FACTOR FOR OVARIAN-CANCER
Authors: LANCASTER JM BROWNLEE HA BELL DA FUTREAL PA MARKS JR BERCHUCK A WISEMAN RW TAYLOR JA
Citation: Jm. Lancaster et al., MICROSOMAL EPOXIDE HYDROLASE POLYMORPHISM AS A RISK FACTOR FOR OVARIAN-CANCER, Molecular carcinogenesis, 17(3), 1996, pp. 160-162
INHIBITION OF THE ERB-2 TYROSINE KINASE RECEPTOR IN BREAST-CANCER CELLS BY PHOSPHOROMONOTHIOATE AND PHOSPHORODITHIOATE ANTISENSE OLIGONUCLEOTIDES
Authors: VAUGHN JP STEKLER J DEMIRDJI S MILLS JK CARUTHERS MH IGLEHART JD MARKS JR
Citation: Jp. Vaughn et al., INHIBITION OF THE ERB-2 TYROSINE KINASE RECEPTOR IN BREAST-CANCER CELLS BY PHOSPHOROMONOTHIOATE AND PHOSPHORODITHIOATE ANTISENSE OLIGONUCLEOTIDES, Nucleic acids research, 24(22), 1996, pp. 4558-4564
TISSUE TRANSGLUTAMINASE EXPRESSION IN HUMAN BREAST-CANCER
Authors: HETTASCH JM BANDARENKO N BURCHETTE JL LAI TS MARKS JR HAROON ZA PETERS K DEWHIRST MW IGLEHART JD GREENBERG CS
Citation: Jm. Hettasch et al., TISSUE TRANSGLUTAMINASE EXPRESSION IN HUMAN BREAST-CANCER, Laboratory investigation, 75(5), 1996, pp. 637-645
CELL-CYCLE CONTROL OF BRCA2
Authors: VAUGHN JP CIRISANO FD HUPER G BERCHUCK A FUTREAL PA MARKS JR IGLEHART JD
Citation: Jp. Vaughn et al., CELL-CYCLE CONTROL OF BRCA2, Cancer research, 56(20), 1996, pp. 4590-4594
P53 OVEREXPRESSION IN ADVANCED-STAGE ENDOMETRIAL ADENOCARCINOMA
Authors: KOHLER MF CARNEY P DODGE R SOPER JT CLARKEPEARSON DL MARKS JR BERCHUCK A
Citation: Mf. Kohler et al., P53 OVEREXPRESSION IN ADVANCED-STAGE ENDOMETRIAL ADENOCARCINOMA, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1246-1252
ROLE OF BRCA1 MUTATION SCREENING IN THE MANAGEMENT OF FAMILIAL OVARIAN-CANCER
Authors: BERCHUCK A CIRISANO F LANCASTER JM SCHILDKRAUT JM WISEMAN RW FUTREAL A MARKS JR
Citation: A. Berchuck et al., ROLE OF BRCA1 MUTATION SCREENING IN THE MANAGEMENT OF FAMILIAL OVARIAN-CANCER, American journal of obstetrics and gynecology, 175(3), 1996, pp. 738-746
LOCALIZED ADENOCARCINOMA OF THE LUNG - ONCOGENE EXPRESSION OF ERBB-2 AND P53 IN 150 PATIENTS
Authors: HARPOLE DH MARKS JR RICHARDS WG HERNDON JE SUGARBAKER DJ
Citation: Dh. Harpole et al., LOCALIZED ADENOCARCINOMA OF THE LUNG - ONCOGENE EXPRESSION OF ERBB-2 AND P53 IN 150 PATIENTS, Clinical cancer research, 1(6), 1995, pp. 659-664
MAINTENANCE OF DNA CONTENT AND ERBB-2 ALTERATIONS IN INTRADUCTAL AND INVASIVE PHASES OF MAMMARY-CANCER
Authors: IGLEHART JD KERNS BJ HUPER G MARKS JR
Citation: Jd. Iglehart et al., MAINTENANCE OF DNA CONTENT AND ERBB-2 ALTERATIONS IN INTRADUCTAL AND INVASIVE PHASES OF MAMMARY-CANCER, Breast cancer research and treatment, 34(3), 1995, pp. 253-263
ANTISENSE DNA DOWN-REGULATION OF THE ERBB2 ONCOGENE MEASURED BY A FLOW CYTOMETRIC ASSAY
Authors: VAUGHN JP IGLEHART JD DEMIRDJI S DAVIS P BABISS LE CARUTHERS MH MARKS JR
Citation: Jp. Vaughn et al., ANTISENSE DNA DOWN-REGULATION OF THE ERBB2 ONCOGENE MEASURED BY A FLOW CYTOMETRIC ASSAY, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8338-8342
GLANDULAR AND STROMAL OVEREXPRESSION OF P53 IN MIXED MALIGNANT MESODERMAL TUMORS (MMMT) - AN ARGUMENT FOR CLONAL ORIGIN
Authors: KRIGMAN HR ELBENDARY A MARKS JR
Citation: Hr. Krigman et al., GLANDULAR AND STROMAL OVEREXPRESSION OF P53 IN MIXED MALIGNANT MESODERMAL TUMORS (MMMT) - AN ARGUMENT FOR CLONAL ORIGIN, Laboratory investigation, 72(1), 1995, pp. 92-92
IDENTIFICATION OF A NEW SUBCLASS OF ALU DNA REPEATS WHICH CAN FUNCTION AS ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTIONAL ENHANCERS
Authors: NORRIS J FAN DJ ALEMAN C MARKS JR FUTREAL PA WISEMAN RW IGLEHART JD DEININGER PL MCDONNELL DP
Citation: J. Norris et al., IDENTIFICATION OF A NEW SUBCLASS OF ALU DNA REPEATS WHICH CAN FUNCTION AS ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTIONAL ENHANCERS, The Journal of biological chemistry, 270(39), 1995, pp. 22777-22782
PROGNOSTIC MODEL OF RECURRENCE AND DEATH IN STAGE-I NONSMALL CELL LUNG-CANCER UTILIZING PRESENTATION, HISTOPATHOLOGY, AND ONCOPROTEIN EXPRESSION
Authors: HARPOLE DH HERNDON JE WOLFE WG IGLEHART JD MARKS JR
Citation: Dh. Harpole et al., PROGNOSTIC MODEL OF RECURRENCE AND DEATH IN STAGE-I NONSMALL CELL LUNG-CANCER UTILIZING PRESENTATION, HISTOPATHOLOGY, AND ONCOPROTEIN EXPRESSION, Cancer research, 55(1), 1995, pp. 51-56
SIMULTANEOUS ENDOMETRIAL MALIGNANT MIXED MESODERMAL TUMOR AND OVARIANSEROUS ADENOCARCINOMA
Authors: KRIGMAN HR COOGAN AC MARKS JR
Citation: Hr. Krigman et al., SIMULTANEOUS ENDOMETRIAL MALIGNANT MIXED MESODERMAL TUMOR AND OVARIANSEROUS ADENOCARCINOMA, Archives of pathology and laboratory medicine, 119(1), 1995, pp. 99-103
IMMUNODETECTION OF P53 PROTEIN IN NONINVASIVE EPITHELIAL PROLIFERATIVE BREAST DISEASE
Authors: HUMPHREY PA FRANQUEMONT DW GEARY WA KERNS BJM IGLEHART JD MARKS JR
Citation: Pa. Humphrey et al., IMMUNODETECTION OF P53 PROTEIN IN NONINVASIVE EPITHELIAL PROLIFERATIVE BREAST DISEASE, Applied immunohistochemistry, 2(1), 1994, pp. 22-28
TRANSFORMING GROWTH-FACTOR-BETA-1 CAN INDUCE CIP1 WAF1 EXPRESSION INDEPENDENT OF THE P53 PATHWAY IN OVARIAN-CANCER CELLS/
Authors: ELBENDARY A BERCHUCK A DAVIS P HAVRILESKY L BAST RC IGLEHART JD MARKS JR
Citation: A. Elbendary et al., TRANSFORMING GROWTH-FACTOR-BETA-1 CAN INDUCE CIP1 WAF1 EXPRESSION INDEPENDENT OF THE P53 PATHWAY IN OVARIAN-CANCER CELLS/, Cell growth & differentiation, 5(12), 1994, pp. 1301-1307
MUTATION AND OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE FREQUENTLY OCCURS IN UTERINE AND OVARIAN SARCOMAS
Authors: LIU FS KOHLER MF MARKS JR BAST RC BOYD J BERCHUCK A
Citation: Fs. Liu et al., MUTATION AND OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE FREQUENTLY OCCURS IN UTERINE AND OVARIAN SARCOMAS, Obstetrics and gynecology, 83(1), 1994, pp. 118-124
Risultati: 1-25 | 26-33